Has any human researcher ever screened a billion compounds in a week? No. AI already discovered a new antibiotic in days, not years, by hunting through chemical space no human could ever map. By 2035, the sheer volume of data, protein structures, and generative chemistry grows exponentially. Human intuition is amazing, but it cannot match that throughput. So ask yourself: when one AI pipeline runs a million virtual trials while a lab runs one, who finds more? The math is not close.

I watched a grad student spend three years synthesizing one molecule that didn't even work. Meanwhile, an AI generated and scored four million novel structures in an afternoon, molecules that have never existed in any human database. So tell me, where did the data for those come from? A flip of the switch, sure, but the same applies to every lab in the world. The real question is: how many new compounds have you personally brought to clinical trials this year? Exactly.

You keep saying "physical" as if pipettes beat pattern recognition, but here's a yes/no question: if an AI-designed drug enters human trials in 2025, does it stop counting just because a robot didn't physically inject the mouse? By 2035, AI will have run more iterative cycles of drug design in silico than every human lab since the beginning of pharmacology. That grad student learns one compound at a time, while AI learns from its own failures at scale. So tell me—which process actually converges on answers faster?

Picture this: an AI generates 100,000 drug candidates in a week. Your lab physically tests twenty. Nineteen fail, but the one that works was AI's top pick—a molecule no human would ever have imagined. Is that a discovery, or does it only count if a human scrawled the formula first? By 2035, human testing capacity is the bottleneck, not AI's ability to find winners. Yes, it learned from our data. Every scientist stands on someone's shoulders. So answer me plainly: is discovery the physical test, or the act of knowing what deserves testing?